Document is current
Any future updates will be listed below
-
Authors
Wexelman, Warren J.
Ciffone, Nicole
Shah, Nishant P.
-
Funding
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
- License Information
-
More Information
Article History
Received: 19 December 2024
Accepted: 13 March 2025
First Online: 22 May 2025
Declarations
:
: Warren J. Wexelman serves as a speaker/advisor for Amgen, Astra Zeneca, Merck, and Novartis. Nishant P. Shah received research grant support from Amgen, Janssen, National Institutes of Health, and Novartis, and serves as a speaker/advisor for Amgen, Esperion, and Novartis. Nicole Ciffone serves as a consultant for Novartis.
: This article does not include any studies with human participants or animals performed by any of the authors.
